UK says new study vindicates delaying 2nd virus vaccine shot

Covid-19: How the UK is using lateral flow tests in the pandemic
4 February 2021
New biomarker may predict which pancreatic cancer patients respond to CD40 immunotherapy
4 February 2021

UK says new study vindicates delaying 2nd virus vaccine shot

Britain’s health chief said Wednesday that a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks supports the government’s strategy of delaying the second shot so it can protect more people quickly with a first dose.

Comments are closed.